- Home
- SLF vs TEVA Comparison
SLF vs TEVA Comparison
Compare SLF & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLF | TEVA |
|---|---|---|
| Founded | 1871 | 1901 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.7B | 40.5B |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SLF | TEVA |
|---|---|---|
| Price | $79.67 | $36.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $84.00 | $38.63 |
| AVG Volume (30 Days) | 753.6K | ★ 4.4M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | N/A | ★ 183.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.68 | $2.97 |
| P/E Ratio | $14.79 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $57.22 | $18.21 |
| 52 Week High | $84.38 | $38.37 |
Technical Indicators
Market Signals| Indicator | SLF | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 50.21 |
| Support Level | $77.31 | $30.42 |
| Resistance Level | $84.38 | $37.17 |
| Average True Range (ATR) | 1.15 | 1.03 |
| MACD | 0.02 | -0.22 |
| Stochastic Oscillator | 52.85 | 25.93 |
Price Performance
Historical ComparisonAbout SLF Sun Life Financial Inc.
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 35% of its 2025 adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 17% of the firm's adjusted earnings in 2025. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.2 trillion total assets under management or administration at the end of 2025 and represents around 30% of the firm's earnings.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.